• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCardiol Therapeutics
    Picture of Cardiol Therapeutics logo

    CRDL — Cardiol Therapeutics News Story

    CA$1.660.000.00%
    ca flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapMomentum Trap
    • Market Cap
      CA$197.42m
    • Enterprise Value
      CA$171.45m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CRDL Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CRDL Dividends
    All News

    NASDAQ TRADE HALT HALT NEWS PENDING AT 08:11 AM

    Picture of Cardiol Therapeutics logoCardiol Therapeutics
    16/01/2026 13:11
    NASDAQ TRADE HALT  CRDL.O  HALT NEWS PENDING AT 08:11 AM
    

    Recent news on Cardiol Therapeutics

    See all news
    • Brief: Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead Of Schedule And Expands Pivotal Trial To Strengthen Assessment Of Cardiolrx's Efficacy

      23/09/2026 11:06
    • Brief: Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus

      10/09/2026 23:31
    • Brief: Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln

      10/09/2026 17:46
    • Brief: Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis

      01/04/2026 13:02
    • NASDAQ RESUMED AT 09:00 AM

      16/01/2026 14:00

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.